Supplementary data taq man primers genes tissue
Mm00441473_m1 GLUT1(Slc2a1) liver BAT WAT muscle 
Mm00446229_m1

GLUT2(Slc2a2) liver
Mm00441483_m1
GLUT3(Slc2a3) WAT
Mm01245502_m1
GLUT4(Slc2a4) BAT WAT muscle
Mm00600311_m1 GLUT5(Slc2a5) WAT muscle Mm00554217_m1 GLUT6(Slc2a6) Mm00444634_m1 GLUT8 (Slc2a8) WAT muscle Mm00455122_m1 GLUT9(Slc2a9) liver Mm01249519_m1 GLUT10(Slc2a10) liver muscle Mm00619244_m1 GLUT12(Slc2a12) WAT muscle Mm00446190_m1 IL-6 liver WAT muscle
Mm01343606_m1
adiponectin WAT
Mm00434759_m1
leptin WAT
Mm01244861_m1
UCP1 BAT
Mm00627598_m1
UCP2 BAT
Mm00494077_m1
UCP3 BAT
Mm01135198_m1
CD36 BAT
Mm01211875_m1
SUPPLEMENTARY METHODS
Western blot analysis:
Cell were grown and stimulated with cinnamaldehyde as described in paragraph: "Ghrelin secretion in MGN3-1 cells: measurements in culture media and gene expression analysis". Cells were collected in NP40 cell Lysis Buffer (Invitrogen) supplemented with PMSF (Sigma-Aldrich) and protease inhibitor (P-2714; Sigma). The equivalent of 1/16 of the total lysate of each well (12 well plate) were resolved by SDS-PAGE and transferred on nitrocellulose membrane. Membranes were incubated overnight in primary antibodies, antiInsulin receptor  (sc-711; Santa Cruz Biotechnology), anti-ghrelin (sc-10368; Santa Cruz Biotechnology) and anti-GOAT (H-032-12; Phoenix pharmaceuticals) diluted 1/200 in blocking buffer 0.1% Tween 20 (Invitrogen) or -tubulin (926-42213; LI-COR) diluted 1/10'000. Primary antibody detection was done using IRDye secondary antibodies (926-32411, 926-32210, 926-32211 ; LI-COR) diluted 1/10'000 in blocking buffer 0.1% Tween 20 and incubated during 1 hour. To perform quantification, -tubulin (926-42213; LI-COR) was detected on membranes stripped (stripping buffer from LI-COR) after the detection of each protein of interest. Detection of the signal was done using ODYSSEY classic Infrared Imaging System (LI-COR).
